Accounts Receivable turnover ratio remained unchanged during the second quarter 2026, compared to the previous quarter at 2.62 indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Average collection period, for Regeneron Pharmaceuticals Inc 's accounts receivable remained unchanged at 139 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 348 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2406, from overall ranking in the first quarter 2026 at 3101.

What is Receivable Turnover Ratio?
What is Regeneron Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

REGN Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	17.03 %	3.06 %	-7.58 %	-6.88 %	-1.87 %
Y / Y Revenue Change	16.73 %	19.04 %	2.51 %	0.9 %	3.62 %
Receivable Turnover Ratio (TTM)	2.62	2.62	2.54	2.47	2.42
REGN's Total Ranking	# 2406	# 3101	# 995	# 3044	# 2970
Accounts Receivable average collection period days	139	139	144	148	151
Seq. Receivable Change	14.56 %	-0.18 %	0.95 %	1.37 %	0.88 %
Seq. Revenue Change	19.01 %	-7.18 %	3.46 %	2.14 %	21.36 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 99
Healthcare Sector	# 349
Overall Market	# 2406

Receivable Turnover Ratio Statistics
High	Average	Low
0.86	0.61	0.37
(Sep 30 2015)		(Dec 31 2025)

REGN Company Profile • Back to REGN Efficiency Comparisons • Compare REGN Receivables Turnover Ratio to its Competitors

Financial Statements
Regeneron Pharmaceuticals Inc 's Accounts Receivable	$ 6,565 Millions	Visit REGN's Balance sheet
Regeneron Pharmaceuticals Inc 's Sales TTM	$ 15,535 Millions	Visit REGN's Income Statement
Sources of REGN's Revenues		Visit REGN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
REGN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
REGN's Growth Rates	REGN's Roa	REGN's Inventory Turnover Ratio	REGN's Dividend Comparisons
REGN's Profitability Ratios	REGN's Roi	REGN's Asset Turnover Ratio	REGN's Dividend Growth
REGN's Valuation Ratios	REGN's Roe	REGN's Financial Strength Ratios	REGN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Moderna Inc	6.49	$ 2,228.000 Millions	$ 343.250 Millions
Intellia Therapeutics Inc	6.44	$ 59.506 Millions	$ 9.243 Millions
Cvrx inc	6.44	$ 60.164 Millions	$ 9.345 Millions
Tarsus Pharmaceuticals Inc	6.43	$ 606.331 Millions	$ 94.240 Millions
Schrodinger Inc	6.43	$ 259.035 Millions	$ 40.267 Millions
Verastem Inc	6.42	$ 87.526 Millions	$ 13.640 Millions
Haemonetics Corporation	6.42	$ 1,351.722 Millions	$ 210.662 Millions
Ufp Technologies Inc	6.40	$ 632.042 Millions	$ 98.785 Millions
Adaptive Biotechnologies Corporation	6.38	$ 308.081 Millions	$ 48.254 Millions
Iradimed Corporation	6.38	$ 86.339 Millions	$ 13.533 Millions
Baxter International Inc	6.37	$ 11,555.000 Millions	$ 1,814.250 Millions
Edap Tms Sa	6.34	$ 111.051 Millions	$ 17.522 Millions
Syndax Pharmaceuticals Inc	6.32	$ 252.004 Millions	$ 39.902 Millions
Nuwellis Inc	6.28	$ 9.013 Millions	$ 1.435 Millions
Puma Biotechnology Inc	6.27	$ 231.244 Millions	$ 36.902 Millions
Absci Corp	6.24	$ 1.561 Millions	$ 0.250 Millions
Insulet Corporation	6.24	$ 3,053.400 Millions	$ 489.200 Millions
Perrigo Company Plc	6.22	$ 4,144.000 Millions	$ 666.050 Millions
Maxcyte inc	6.22	$ 31.051 Millions	$ 4.994 Millions
Cue Biopharma Inc	6.21	$ 37.654 Millions	$ 6.064 Millions
Heartflow Inc	6.20	$ 210.791 Millions	$ 33.999 Millions
Omada Health Inc	6.20	$ 308.445 Millions	$ 49.770 Millions
Vertex Pharmaceuticals Inc	6.19	$ 12,587.200 Millions	$ 2,032.400 Millions
Orthofix Medical Inc	6.17	$ 833.344 Millions	$ 135.037 Millions
Harvard Bioscience Inc	6.16	$ 88.164 Millions	$ 14.306 Millions
Genedx Holdings Corp	6.16	$ 455.446 Millions	$ 73.962 Millions
Gilead Sciences Inc	6.15	$ 30,457.000 Millions	$ 4,951.000 Millions
Integra Lifesciences Holdings Corp	6.14	$ 1,647.666 Millions	$ 268.153 Millions
Zoetis Inc	6.13	$ 9,517.000 Millions	$ 1,552.000 Millions
Interpace Biosciences Inc	6.12	$ 36.519 Millions	$ 5.963 Millions

Date modified: 2026-09-15T07:24:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.